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Abstract
Background: The Fat mass and obesity gene (FTO) has been identified through genome wide association studies
as an important genetic factor contributing to a higher body mass index (BMI). However, the molecular context in
which this effect is mediated has yet to be determined. We investigated the potential molecular network for FTO
by analyzing co-expression and protein-protein interaction databases, Coxpresdb and IntAct, as well as the
functional coupling predicting multi-source database, FunCoup. Hypothalamic expression of FTO-linked genes
defined with this bioinformatics approach was subsequently studied using quantitative real time-PCR in mouse
feeding models known to affect FTO expression.
Results: We identified several candidate genes for functional coupling to FTO through database studies and
selected nine for further study in animal models. We observed hypothalamic expression of Profilin 2 (Pfn2), cAMP-
dependent protein kinase catalytic subunit beta (Prkacb), Brain derived neurotrophic factor (Bdnf), neurotrophic
tyrosine kinase, receptor, type 2 (Ntrk2), Signal transducer and activator of transcription 3 (Stat3), and Btbd12 to be
co-regulated in concert with Fto. Pfn2 and Prkacb have previously not been linked to feeding regulation.
Conclusions: Gene expression studies validate several candidates generated through database studies of possible
FTO-interactors. We speculate about a wider functional role for FTO in the context of current and recent findings,
such as in extracellular ligand-induced neuronal plasticity via NTRK2/BDNF, possibly via interaction with the
transcription factor CCAAT/enhancer binding protein b (C/EBPb).
Background
Genome-wide association studies consistently show that
fat mass and obesity-related gene (FTO) gene poly-
morphism is the strongest known genetic factor asso-
ciated with the development of higher BMI and obesity
[1-5]. Several single nucleotide polymorphisms (SNPs)
in this gene have been linked with elevated BMI in var-
ious populations [3,6-12]. Recent studies have shown
that FTO risk alleles are preferentially transcribed in
heterozygote individuals, and this is facilitated by
increased binding of transcription factor CUX1 to the
regulatory elements in FTO intron 1 [13-15]. Transgenic
mice carrying additional copies of the Fto gene also
show an Fto expression-dependent body weight
response [16].
Data obtained in studies on Fto knockout and mutant
mice (FtoI367A) suggest that FTO is involved in energy
homeostasis, metabolism and adipogenesis [17].
Hypothalamic FTO is highly regulated in mouse and rat
feeding models [18,19]. However, our knowledge of the
molecular and physiological functions of FTO is still
very limited. The FTO protein has some structural simi-
larities to canonical demethylase enzymes and its
demethylating activity has been demonstrated in vitro
[20]. Recent data suggest a role for FTO in co-regula-
tion of transcription. Using a reporter assay, Wu et al.
were able to observe co-expression of FTO and
CCAAT-enhancer binding protein b (C/EBPb) to
increase expression of a reporter gene driven by a C/
EBP response element (CEBPRE). This element
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contained three CpG-sites for methylation and addi-
tional analysis showed coexpression of FTO and C/
EBPb to partially attenuate the reduced reporter gene
expression induced by methylation of CEBPREs [21]. C/
EBPb can be termed an “early-response” transcription
factor, as it links extracellular signaling pathways to
gene regulation and long-term changes in the cell’s dif-
ferentiation. It has been associated with a wide range of
functions, from adipogenesis and energy homeostasis
control to immune responses, neuroprotection, and
synaptic plasticity [22,23]. In line with that, dysregula-
tion of FTO may lead not only to the impairment of
energy homeostasis, but also to other abnormalities,
including improper formation of neuronal networks. For
example, a rare loss-of-function mutation documented
in a Palestinian family showed that FTO deficiency leads
to growth retardation and severe developmental defects
of the central nervous system [24].
In order to determine a molecular mechanistic context
for FTO, we utilized information from co-expression-,
and protein-protein interaction databases and identified
nine candidate genes for functional coupling to FTO.
We then performed qRT-PCR expression analysis of
murine hypothalami to detect whether the network can-
didate genes were co-regulated with FTO in a feeding
restriction paradigm known to affect FTO expression in
a differential manner. We found changes in the expres-
sion of Pfn2, Prkacb and Bdnf to parallel FTO mRNA
upregulation during food deprivation. We also observed
co-regulation of Fto and brain-derived neurotrophic fac-
tor (Bdnf) and its receptor TrkB (Ntrk2) in the sated
state, and of Fto and Btbd12, Pfn2 and Stat3 in the
food-deprived state.
Methods
Databases and gene interaction analysis
The FunCoup database (http://funcoup.sbc.su.se) pre-
dicts protein functional coupling through integration of
data from a number of high-throughput functional
assays. It uses information from 51 data sets containing
mRNA and protein co-expression, protein-protein inter-
action, subcellular colocalization, phylogenetic profile
similarity, shared transcription factor binding, shared
miRNA targeting and domain associations. The database
uses Bayesian statistics to predict the probability of func-
tional coupling between two proteins and presents this as
a probabilistic confidence value pfc) ranging from 0 to 1
[25]. The Coxpresdb (coexpressed gene database) (http://
coxpresdb.jp) uses Affymetrix GeneChip array data
(Human Genome U133 plus 2.0 array and Mouse Gen-
ome 430 2.0 array) and presents interactions between
genes based on probe-to-probe expression pattern simila-
rities and estimates the strength of the interaction by
combining the ranks of co-expression for the
corresponding gene pair [26]. The protein-protein inter-
action database IntAct (http://www.ebi.ac.uk/intact/main.
xhtml) collects data from protein-protein interaction
experiments, e.g. yeast two hybrid screenings and co-
immunoprecipitation assays. The database allows sub-
missions from independent research groups and cur-
rently encompasses data on approximately 200,000
protein-protein interactions in several species. IntAct
also contains links to the publications describing the
interactions [27]. Databases were queried in default set-
tings with “FTO” as the search term. Human FTO inter-
actions were queried in Funcoup and results for the
human FTO gene were selected in the Coxpresdb
database.
Mouse feeding models
In the gene expression analysis, we utilized the tissue
collected in the experiments described previously [19].
In short, male C57BL/6J mice (Scanbur, Sweden) were
housed individually or in groups of two in macrolon
cages with LD 12:12 (lights on at 07.00). Animals were
twelve weeks old at the beginning of the experiment.
Water and standard chow (Lactamin, Sweden) were
available ad libitum unless specified otherwise. All ani-
mal procedures were approved by the Uppsala Animal
Ethical Committee (ID: C228/7 & C262/7) and followed
the guidelines of Swedish legislation on animal experi-
mentation (Animal Welfare Act SFS1998:56) and Eur-
opean Union legislation (Convention ETS123 and
Directive 86/609/EEC).
16-hr food deprivation
Chow was removed just before the onset of darkness
and mice were sacrificed 16 hours later. Control mice
had ad libitum access to chow. Each group contained 8
animals. Hypothalami were dissected and immersed in
RNAlater.
Ad libitum chow fed cohort
A larger group of ad libitum chow fed animals was used
to better study co-regulation of FTO with other genes.
10 group-housed mice had ad libitum access to chow
for 48 hours before sacrifice and dissection of
hypothalami.
Generation of cDNA and qRT-PCR
The tissue was kept in RNAlater at room temperature
for 2 h and then stored at -80°C until further proces-
sing. Tissues were homogenized by sonification (Bran-
son sonifier B 15) and RNA was purified from the
samples using the TRIzol (Sigma-Aldrich, Sweden)
method [28]. Samples were treated with Dnase I (Roche
Diagnostics, Scandinavia) to remove residual DNA con-
tamination. DNA contamination after Dnase I treatment
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was checked with PCR. Complementary DNA, cDNA,
was then generated using reverse MLV reverse tran-
scriptase (Invitrogen, Sweden) according to the manu-
facturer’s specifications. PCR reactions were run in a
total volume of 20 ul using Taq polymerase (Biotools,
Sweden). Each reaction was performed in duplicate and
contained 75 mM Tris/HCL, 50 mM KCl and 20 mM
(NH4)2SO4, 4 mM MgCl2, 0.25 mM dNTPs, 1:20
DMSO, 20 mU/ul Taq polymerase, 50 mM forward and
reverse primer and 1:4 SYBR-green (Invitrogen, Swe-
den). Reactions were run on iCycler temperature cyclers
and fluorescence was measured using MyiQ single color
real time PCR detection system. Data were analyzed
using iQ5 software (BioRad, Sweden). Gene expression
was normalized between the samples using the geo-
metric mean of the most stable housekeeping genes, in
accordance with the geNorm-method as previously pub-
lished by Vandesompele et al. [29].
Statistical analysis
D’agostino & Pearson omnibus normality test was used
to test normal distribution of gene expression data. Stu-
dent’s t-test was used to test the difference in gene
expression between ad libitum chow fed, and food
restricted mice. Linear regression was used to determine
the relationship between expression of FTO and candi-
date genes. FTO was considered to correlate to candi-
date genes if the slope of the trendline significantly
deviated from zero. For all tests nominal p-values < 0.05
were considered significant. The statistical analysis was
performed with Prism v5.02 (GraphPad Software, San
Diego, California, USA, http://www.graphpad.com).
Results
Database analysis suggests several FTO-interaction
candidates
The FTO-interaction networks generated by Coxpresdb
and FunCoup are presented in Figure 1 and genes
selected for further analysis are presented in Table 1. A
cut-off pfc-value of 0.4 was selected to remove the
weakest interactions generated by the FunCoup data-
base (see Figure 1a). The four genes with the highest
pfc-score were then selected for analysis in animal mod-
els (Table 1). Candidate genes in close proximity to
FTO in the network generated by Coxpresdb, were
selected for further analysis. The FLJ42393-transcript
was excluded from further analysis as it does not
encode a functional protein according to Ensembl. The
gene encoding neurolysin (NLN) was included instead
due to its high connectivity and proximity to several
candidate FTO interactors generated by this database
(Figure 1a). We were unsuccessful in generating primers
for the Aft7ip gene. The IntAct database generated only
one candidate gene, SLX4 structure-specific endonu-
clease subunit homolog (BTBD12). This interaction was
observed in an anti-tag co-immunoprecipitation experi-
ment aimed at finding protein-protein interactions to
BTBD12 [30].
Figure 1 Network images of FTO and candidates genes. Coxpresdb (a) extracts expression data from affymetrix gene-chip arrays (human
genome u133 plus 2.0 array and mouse genome 430 2.0 array) run on 3749 human and 2226 mouse samples [26]. The FunCoup database (b)
integrates heterogenous data from 51 unique datasets, containing information on mRNA co-expression, protein-protein interaction, sub-cellular
location etc., and uses Bayesian statistics to generate a probabilistic score for functional coupling between genes [25].
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Feeding deprivation causes up-regulation of
hypothalamic Fto, Pfn2 and Prkacb as well as down-
regulation of Bdnf
Fto was significantly upregulated in the hypothalamus of
food-deprived mice (p = 0.0012) in good agreement
with previously published findings [18,19]. Several FTO
network interaction candidates were also regulated in
these mice (Figure 2). Pfn2 showed a twelve-fold
increase in expression (p = 0.0001). Prkacb was up-regu-
lated as well (p = 0.0017). Bdnf, the ligand for Ntrk2,
was down-regulated in food-deprived mice (P = 0.04).
Ntrk2 and Stat3 showed a trend toward up-regulation,
however these differences did not reach statistical signif-
icance (p = 0.07 and p = 0.17, respectively). We also
observe hypothalamic expression levels of Pfn2, Stat3
and Btbd12 to correlate with Fto-expression in food
deprived mice but not in chow fed mice (see Figure 3).
Hypothalamic FTO is co-regulated with Ntrk2 and BDNF
in chow fed mice
In the cohort of 48 hour chow fed mice we observed the
expression of FTO to show a higher degree of variation
compared to chow fed animals in the 16 hour paradigm,
which is most likely due to larger individual differences
in food consumption. The variation in gene expression
was shown to follow a normal distribution. Analysis also
showed that Ntrk2-expression correlated positively to
expression of Fto (p = 0.0105) while Bdnf correlated
negatively (p = 0.0193) (see Figure 3 & Table 2).
Discussion
We identified nine candidate genes for functional cou-
pling and interaction to FTO through database analysis
and previous publications. In order to test the validity of
this network, expression of network candidate genes was
analyzed in a food deprivation model known to induce
up-regulation of Fto. We confirmed increased levels of
Fto mRNA and observed simultaneous up-regulation of
four out of the nine genes in the hypothalamus during
food deprivation: Pfn2, Prkacb, TrkB and Stat3; as well
as down-regulation of Bdnf. Bdnf, Ntrk2 and Stat3 have
been previously implicated in the regulation of energy
homeostasis. Bdnf inhibits feeding and increases energy
expenditure when injected into the ventromedial
hypothalamus (VMH) and paraventricular nucleus of
the hypothalamus (PVN) [31-34]. Stat3 is required for
the anorexic effect of leptin-receptor signalling in the
ARH [35]. Stat3 is also up-regulated in response to
overexpression of AAV injection-induced Fto overex-
pression in the arcuate nucleus [36]. However, two of
the genes, Prkacb and Pfn2, have not previously been
implicated in any feeding/obesity paradigms. Intrigu-
ingly, we observed the expression of Fto to correlate
with expression of Ntrk2 and Bdnf in the hypothalamus
of chow-fed mice (p = 0.019 and 0.011, respectively)
(Figure 3 & Table 2). We also observed a strong linear-
ity between Fto expression and that of Ntrk2 and Bdnf
(R2 = 0.52 and 0.63, respectively) (Table 2).
The expression and co-regulation analysis provides
additional evidence for a functional coupling of FTO to
the network candidate genes and validates these data-
bases in terms of co-expression [37,38]. From this view-
point, FunCoup has provided the most valuable leads as
the genes it reports as candidates are shown not only to
be regulated during starvation in a similar way as Fto,
but also follows the expression of Fto in a linear fashion.





PFN2 Profilin 2 Regulates actin polymerization in response to extracellular signals
NRTK2 Neurotrophic tyrosine kinase receptor type 2 Receptor for BDNF
BDNF Brain derived neurotrophic factor involved in neuronal plasticity & differentiation
PRKACB cAMP dependent protein kinase catalytic
subunit beta
Ser/Thr protein kinase, catalytic subunit of AMP-activated protein kinase (AMPK)
VAMP2 Vesicle-associated membrane protein 2. alt.
Synaptobrevin-2
Involved in the targeting and/or fusion of transport vesicles to their target
membrane.
STAT3 Signal transducer and activator of transcription
3
Transcription factor involved in cell growth and apoptosis. Responds to leptin
signalling.
NLN Neurolysin Hydrolyzes oligopeptides such as neurotensin, bradykinin and dynorphin A
BTBD12 SLX4 structure-specific endonuclease subunit
homolog
DNA-repair, endonuclease activity.
ZBTB20 Zinc finger and BTB domain-containing protein
20
May be a transcription factor that may be involved in hematopoiesis, oncogenesis,
and immune responses
ATF7IP Activating transcription factor 7-interacting
protein
A regulator of telomerase reverse transcriptase (TERT) expression
STAT3 was included in our analysis due to previous publications suggesting a link between this gene and FTO [36].
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FTO has been shown to exhibit de-methylase activity
[20] with a putative role in epigenetic regulation of gene
expression. However, a recent study found evidence that
FTO increased binding of transcription factor CCAAT-
enhancer binding protein beta (C/EBPb) to methylated
as well as de-methylated promoter sites. This study sug-
gests a unique functional role for FTO: the enabling of
transcription factors to bypass methylation specific epi-
genetic control of gene expression [21]. Also of great
interest is that C/EBPb has been reported to mediate
the immediate early gene response induced by BDNF
signaling via NTRK2 [39], by acting as an inducible
transcription factor downstream of MAPK/ERK in the
NTRK2 signaling pathway. We have prepared a
hypothetical model for the involvement of FTO in the
BDNF-NTRK2 signaling pathway, which integrates our
data and previous findings on BDNF-NTRK2, FTO and
C/EBPb (Figure 4).
Based on our observations, we speculate that FTO
may affect the regulation of ligand-induced neuronal
plasticity via BDNF-NTRK2, PRKACB, STAT3 and
PFN2. BDNF is involved in neuronal survivability, differ-
entiation and formation of memory [40] and has also
been associated to obesity in recent GWA-studies [41].
Pfn2-encoded profyllin 2 regulates important cellular
functions such as endocytosis, vesicle recycling and
actin assembly in CNS neurons [42]. Its effect on actin
turnover may indicate a function in the regulation of
neuronal plasticity in response to food intake. Neuronal
plasticity occurs e.g. in the arcuate nucleus (ARH) in
response to leptin signaling [43] and within the ARH -
Figure 2 mRNA expression levels in hypothalamus of 16 hour food deprived vs chow fed mice. Asterisks denote significance of Student’s
t-test for difference of means. * = p < 0.05, ** = p < 0.005, *** = p < 0.001, # denotes trend towards significance, p < 0.10.
Figure 3 Analysis of mRNA expression measured with
quantitative RT-PCR. (a) Hypothalamic expression of Ntrk2 and
Bdnf correlates with Fto expression in 48 hour ad libitum chow fed
mice. (b) Hypothalamic expression of Btbd12, Pfn2 and Stat3
correlates with Fto-expression in 16 hr food restricted mice, where
Fto is upregulated (see figure 2).
Rask-Andersen et al. BMC Neuroscience 2011, 12:117
http://www.biomedcentral.com/1471-2202/12/117
Page 5 of 9
PVN pathways which develop during the perinatal per-
iod [44]. Interestingly, some FTO polymorphisms are
associated with lower brain volumes in the frontal and
occipital lobes [45]. As obesity itself is in some cases
also associated with lower brain volume as well as cog-
nitive deficits [46], FTO may be one of the genes brid-
ging body weight dysregulation and other physiological
abnormalities that oftentimes accompany abnormally
low or high body weight. PRKACB (cAMP-dependant
protein kinase catalytic subunit beta) encodes a catalytic
subunit isoform of the protein kinase A holoenzyme
(PKA). PRKACB phosphorylates the transcription factor,
cAMP-response element-binding protein (CREB). CREB,
in turn, regulates expression of several genes, including
CEBPb, BDNF, NTRK2, NPY and the glucocorticoid
receptor. PRKACB has been linked to depression as
lower expression of PRKACB in the prefrontal cortex
occurs in major depression [47]. STAT3 is a transcrip-
tion factor involved in cell growth, embryogenesis, apop-
tosis and cell motility. It is also one of the mediators of
leptin signaling and regulates the expression of appetite
regulators Agouti related peptide (AGRP) and pro-opio-
melanocortin (POMC) [48]. This again suggests the
potential role of Fto and its network of genes as a com-
mon molecular mechanism underlying co-regulation of
body weight and processes related to cognition.
Conclusions
We identified several candidate genes for functional
coupling to FTO through database analysis and vali-
dated these by expression studies in relevant feeding
models via qRT-PCR. Based on these findings, we
hypothesized about the molecular context of FTO, dis-
cussing a putative involvement in neuronal plasticity by
association to transcription factors downstream of ligand
activated signaling pathways such as BDNF/NTRK2.
These functional results provide new ideas for deducing
the mechanisms affected by obesity related FTO-risk
alleles.
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food restriction paradigm. Hypothalamic expression of Ntrk2 and Bdnf correlate to Fto-expression positively and negatively, respectively, in ad libitum chow fed
mice. Pfn2, Stat3 and Btbd12 were positively correlated to expression of Fto in hypothalami of 16 hour food restricted mice.
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Figure 4 In silico analysis and gene expression studies suggests functional coupling between FTO and the BDNF/NTRK2-signalling
pathway. Ablation of C/EBPs has been shown to reduce the expression of transcription factors Egr1, Egr2 (early growth response protein 1 and
2) and Fos (proto-oncogene c-Fos) following BDNF exposure in cultured neuronal cells [21,39] linking BDNF-NTRK2 to gene transcription via C/
EBPs. C/EBPb is a substrate for phosphorylation by MAPK, one of three downstream pathways of BDNF-NTRK2 signalling [49,50]. C/EBPs mediate
the immediate early gene response of NTRK2-signalling. Recent findings by Wu et al. suggest FTO to attenuate epigenetic control of gene
regulation via methylation of CpG-sites in C/EBPb response elements (CEBPREs) [21]. In silico analysis, as well as expression studies, point to a
functional coupling between FTO and the BDNF/NTRK2-signalling pathway, potentially mediated by the increased binding of C/EBPb methylated
response elements
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